The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy.

Cao L, Li K, Li Q, Tong Q, Wang Y, Huang L

Open source

DOI: 10.1186/s12943-025-02475-8
Published: 2025 Nov 7
Container: Molecular cancer
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-025-02475-8,
  title = {The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy.},
  author = {Cao L and Li K and Li Q and Tong Q and Wang Y and Huang L},
  year = {2025},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-025-02475-8},
  url = {https://doi.org/10.1186/s12943-025-02475-8}
}

RIS

TY  - JOUR
TI  - The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy.
AU  - Cao L
AU  - Li K
AU  - Li Q
AU  - Tong Q
AU  - Wang Y
AU  - Huang L
PY  - 2025
JO  - Molecular cancer
DO  - 10.1186/s12943-025-02475-8
UR  - https://doi.org/10.1186/s12943-025-02475-8
ER  -

APA

L, C., K, L., Q, L., Q, T., Y, W., & L, H. (2025). The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy.. Molecular cancer. https://doi.org/10.1186/s12943-025-02475-8

Source records

pubmed · retrieved 2026-09-25T05:00:38.608Z
europe-pmc · retrieved 2026-09-25T05:00:38.644Z
doaj · retrieved 2026-09-25T05:00:38.606Z